Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

CUMBERLAND PHARMS

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 36
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

CIPLA

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 43
  • 0 comments

FDA approve EMTRICITABINE

Comment Full text

HORIZON

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 50
  • 0 comments

FDA approve FAMOTIDINE; IBUPROFEN

Comment Full text

CURRAX

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 45
  • 0 comments

FDA approve NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 41
  • 0 comments

FDA approve OXALIPLATIN

Comment Full text

ZYLA

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 41
  • 0 comments

FDA approve DICLOFENAC

Comment Full text

ASSERTIO

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 48
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

BOEHRINGER INGELHEIM

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 41
  • 0 comments

FDA approve MELOXICAM

Comment Full text

UPJOHN

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 47
  • 0 comments

FDA approve CELECOXIB

Comment Full text

IBSA INST BIO

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 47
  • 0 comments

FDA approve DICLOFENAC EPOLAMINE

Comment Full text
  • Previous
  • 307
  • 308
  • 309
  • 310
  • 311
  • Next

Search

News categories

  • Technical Exchange News(11495)
  • Event(3373)
  • SEC News(216218)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137395)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin